Form 4: CHCT CEO Takes Salary in Stock, Boosts Holdings
Insider Transaction Report
Community Healthcare Trust CEO David H. Dupuy increased his direct beneficial ownership by acquiring 29,941 shares of common stock as part of his 2026 compensation plan.
Summary
- CEO David H. Dupuy acquired 29,941 shares of Community Healthcare Trust Inc. common stock on January 15, 2026.
- The acquisition price was $16.70 per share, based on the average price for the 10 trading days immediately preceding the transaction date.
- This transaction increased his direct beneficial ownership to 534,245 shares.
- The shares were acquired as part of his 2026 compensation, where he elected to take 50% of his base salary in restricted stock with a five-year restriction period.
- As a result of this election, the company awarded him additional restricted stock equal to 25% of his annual salary.
Sentiment
Score: 8
Explanation: The CEO's decision to take a significant portion of his salary in restricted stock, along with an additional award, demonstrates strong confidence in the company's long-term prospects and aligns his interests directly with shareholders, indicating a very positive sentiment.
Positives
- Increased alignment of the CEO's interests with shareholders due to a significant portion of his compensation being stock-based.
- The CEO's decision to take 50% of his salary in restricted stock demonstrates strong confidence in the company's long-term performance and future prospects.
- The additional 25% restricted stock award further incentivizes long-term commitment and performance from the CEO.
Negatives
- None directly identified for the company in this filing.
Risks
- No specific risks to the company's operations or financial health are disclosed in this insider transaction report.
Future Outlook
The five-year restriction period on the restricted stock implies a long-term commitment from the CEO, aligning his incentives with the company's sustained performance over the coming years.
Management Comments
- CEO David H. Dupuy's decision to take 50% of his 2026 salary in restricted stock with a five-year restriction period, coupled with an additional 25% restricted stock award, signals strong confidence in the company's future and aligns his interests with long-term shareholder value.
Industry Context
The use of stock-based compensation for executives is a common practice across many industries, including healthcare REITs, to align management incentives with shareholder interests and promote long-term value creation.
Comparison to Industry Standards
- Many public companies, particularly in the REIT sector, utilize equity-based compensation to incentivize executives. The specific structure, where 50% of the CEO's salary is taken in restricted stock with an additional 25% award, represents a significant commitment to equity incentives, which is generally viewed as a strong positive in corporate governance practices.
- While specific comparable company compensation details are not provided in this filing, a high proportion of equity-based compensation for a CEO is often seen as a robust mechanism for aligning leadership with long-term shareholder returns, a standard often sought by institutional investors.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Executive Compensation Structure | CEO David H. Dupuy elected to receive 50% of his 2026 base salary in restricted stock with a five-year restriction period. The company also awarded him additional restricted stock equal to 25% of his annual salary as a result of this election. | 01/15/2026 | Enhances alignment between executive incentives and long-term shareholder value, promoting sustained company performance and demonstrating strong confidence from leadership. |
Related Party Transactions
- Compensation agreement for CEO David H. Dupuy involving the issuance of restricted stock as part of his 2026 salary and an additional award, representing a transaction between the company and a related party (its CEO).
Stakeholder Impact
- Shareholders: Positive impact due to increased alignment of the CEO's interests with long-term shareholder value and demonstrated confidence in the company's future.
- Management: The CEO's compensation structure is directly impacted, with a significant portion tied to long-term stock performance, fostering a long-term perspective.
Next Steps
- The restricted stock acquired by the CEO is subject to a five-year restriction period, indicating a long-term holding commitment.
Key Dates
| Date | Description |
|---|---|
| 01/15/2026 | Date of transaction where David H. Dupuy acquired 29,941 shares of common stock as part of his 2026 compensation. |
| 01/20/2026 | Date the Statement of Changes in Beneficial Ownership (Form 4) was signed. |
Recommendation
buyThe CEO's decision to take a substantial portion of his 2026 salary in restricted stock, coupled with an additional equity award, signals strong confidence in the company's future performance and aligns his financial interests directly with long-term shareholder value. This significant insider buying behavior, particularly from the CEO, is generally viewed as a strong positive indicator for the stock, suggesting a favorable outlook for long-term investors.
Keywords
CHCT, Community Healthcare Trust, David H. Dupuy, CEO, stock acquisition, restricted stock, insider transaction, executive compensation, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.